Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical TrialsPiotr Rutkowski, Scott M. Schuetze, Brian P. Rubin et al.|Journal of Clinical Oncology|2010Cited by 401
Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trialAlexander M.M. Eggermont, Danielle Líénard, Stefan Suciu et al.|The Lancet|2005Cited by 314